204259-56-3
204259-56-3
Chemical Structure
L-Octanoylcarnitine-d3
- CAS No.: 204259-56-3
- Formula:C15H26D3NO4
- Molecular Weight:290.41
InChIKey: CXTATJFJDMJMIY-SZIUSNIFSA-N
SMILES: CCCCCCCC(O[C@H](CC([O-])=O)C[N+](C([2H])([2H])[2H])(C)C)=O
Biological Activity: L-Octanoylcarnitine-d3 is the deuterium-labeled L-Octanoylcarnitine (HY-113161). L-Octanoylcarnitine-d3 is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine-d3 can be used for the research of breast cancer[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Octanoylcarnitine-d3 | L-Octanoylcarnitine-d3 is the deuterium-labeled L-Octanoylcarnitine (HY-113161). L-Octanoylcarnitine-d3 is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine-d3 can be used for the research of breast cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Octanoylcarnitine (Standard) | ≥98% | L-Octanoylcarnitine (Standard) is the analytical standard of L-Octanoylcarnitine. This product is intended for research and analytical applications. L-Octanoylcarnitine is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine can be used for the research of breast cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Octanoylcarnitine-d9 | 99.9% | L-Octanoylcarnitine-d9 is deuterium labeled L-Octanoylcarnitine. L-Octanoylcarnitine is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine can be used for the research of breast cancer.. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Octanoylcarnitine | 98.0% | L-Octanoylcarnitine is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine can be used for the research of breast cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
